
The Opportunity for Digital Innovation in Oncology Drug Development
Solving three major challenges in the development of new oncology drugs
Solving three major challenges in the development of new oncology drugs
When you don’t know your patients well, you risk compromising their care, trust, and business. There is limited capability to address health equity and effectively adopt value-based care models if an organization does not prioritize identity management.
Digital identity proofing via mobile phone or desktop enables consumers to take personal control of their identity, solving many of the frustrations that occur during care interactions, including everything from redundant paper forms to registration and wait times.
We know that inadequate and inconsistent patient identification places patients at risk for medical errors but the problem goes far beyond protecting individual patient safety